Asgn (ASGN) EBITDA (2016 - 2025)
Historic EBITDA for Asgn (ASGN) over the last 16 years, with Q3 2025 value amounting to $37.7 million.
- Asgn's EBITDA fell 2096.44% to $37.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.8 million, marking a year-over-year decrease of 2997.86%. This contributed to the annual value of $170.2 million for FY2024, which is 2333.33% down from last year.
- Per Asgn's latest filing, its EBITDA stood at $37.7 million for Q3 2025, which was down 2096.44% from $31.9 million recorded in Q2 2025.
- Asgn's 5-year EBITDA high stood at $214.6 million for Q3 2021, and its period low was $21.7 million during Q1 2025.
- For the 5-year period, Asgn's EBITDA averaged around $61.3 million, with its median value being $51.9 million (2023).
- In the last 5 years, Asgn's EBITDA surged by 28806.51% in 2021 and then crashed by 6691.52% in 2022.
- Asgn's EBITDA (Quarter) stood at $85.0 million in 2021, then crashed by 32.82% to $57.1 million in 2022, then fell by 9.11% to $51.9 million in 2023, then dropped by 23.89% to $39.5 million in 2024, then decreased by 4.56% to $37.7 million in 2025.
- Its last three reported values are $37.7 million in Q3 2025, $31.9 million for Q2 2025, and $21.7 million during Q1 2025.